原標(biāo)題：過敏性疾病的微生物組學(xué)：目前的認(rèn)識和今后的機(jī)遇：美國過敏、哮喘和免疫學(xué)會和歐洲過敏與臨床免疫學(xué)會2017PRACTALL文件
　　PRACTALL是由美國過敏、哮喘與免疫學(xué)會(American Academy of Allergy, Asthma & Immunology)和歐洲過敏與臨床免疫學(xué)會(European Academy of Allergy and Clinical Immunology)聯(lián)合發(fā)起的，旨在就過敏癥與免疫學(xué)領(lǐng)域的前沿課題提供基于證據(jù)的共同建議。PRACTALL 2017側(cè)重于研究已證實的微生物在哮喘、特應(yīng)性皮炎和食物過敏患者中的作用。通過概述有關(guān)其在變應(yīng)性疾病中的作用的重要知識空白以及填補(bǔ)這些空白所必需的策略。此外，還將對處置微生物組的方法上的進(jìn)展進(jìn)行回顧，確定哪些是有效的，哪些是無效的，以及作為將來干預(yù)過敏性疾病形成、進(jìn)展或兩者的基礎(chǔ)。


　　延伸閱讀


JACI
The microbiome in allergic disease: Current understanding and future opportunities—2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical  Immunology
https://doi.org/10.1016/j.jaci.2017.02.007
Abstract:
PRACTALL is a joint initiative of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based recommendations on cutting-edge topics in the field of allergy and immunology. PRACTALL 2017 is focused on what has been established regarding the role of the microbiome in patients with asthma, atopic dermatitis, and food allergy. This is complemented by outlining important knowledge gaps regarding its role in allergic disease and delineating strategies necessary to fill these gaps. In addition, a review of progress in approaches used to manipulate the microbiome will be addressed, identifying what has and has not worked to serve as a baseline for future directions to intervene in allergic disease development, progression, or both.
First Author:
Yvonne J.Huang
Correspondence:
Thomas A.Fleisher
All Authors:
YvonneJ.HuangMDaBenjaminJ.MarslandPhDbSupindaBunyavanichMD,MPH,MPhilcLiamO'MahonyPhDdDonald Y.M.LeungMD, PhDeAntonellaMuraroMD, PhDfMDg
Joseph HernandezMD, PhD ?Scott D.BoydMD, PhD Stephen J.Galli MD   
　　創(chuàng)建過敏性疾病的科研、科普知識交流平臺，為過敏患者提供專業(yè)診斷、治療、預(yù)防的共享平臺。